A Real-world Prospective Study of Mother-to-child Transmission of HBV in China Using a Mobile Health Application (Shield 01)
Open Access
- 5 March 2020
- journal article
- research article
- Published by Xia & He Publishing in Journal of Clinical and Translational Hepatology
- Vol. 8 (X), 1-8
- https://doi.org/10.14218/jcth.2019.00057
Abstract
Background and Aims: The World Health Organization (WHO) Western Pacific Region set a target of eliminating mother-to-child transmission (MTCT) of hepatitis B virus (HBV) by 2030. To assess the feasibility of this target in China, we carried out an epidemiological study to investigate the status quo of MTCT in the real-world setting.This publication has 29 references indexed in Scilit:
- Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 updateHepatology International, 2015
- Chronic hepatitis B infection in pregnancyWorld Journal of Hepatology, 2015
- Evaluation of policies and practices to prevent mother to child transmission of hepatitis B virus in China: Results from China GAVI project final evaluationVaccine, 2013
- Telbivudine Prevents Vertical Transmission From HBeAg-Positive Women With Chronic Hepatitis BClinical Gastroenterology and Hepatology, 2012
- Effects of Maternal Screening and Universal Immunization to Prevent Mother-to-Infant Transmission of HBVGastroenterology, 2012
- Comprehensive analysis of the prevalence of hepatitis B virus escape mutations in the major hydrophilic region of surface antigenJournal of Medical Virology, 2011
- A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infectionJournal of Hepatology, 2011
- Hepatitis B vaccination: The key towards elimination and eradication of hepatitis BJournal of Hepatology, 2009
- Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothersEmergencias, 2006
- Vaccine-induced escape mutant of hepatitis B virusThe Lancet, 1990